You are here: Home » International » News » Others
Business Standard

From storage to transport, hurdles to getting Covid vaccine to N Koreans

North Korea has not responded to offers of aid from South Korea and international vaccine-sharing programmes, but prefers U.S.-made Moderna and Pfizer over China's Sinovac orUK's Astrazeneca shots

Topics
Coronavirus Vaccine | North Korea

Reuters  |  Seoul 

Covid vaccine, covid-19
As North Korea battles its first known Covid outbreak, a lack of storage, chronic power shortages and inadequately trained medical staff pose acute challenges to inoculating its 25 million people.

As battles its first known COVID outbreak, a lack of storage, chronic power shortages and inadequately trained medical staff pose acute challenges to inoculating its 25 million people - even with outside help, analysts said.

has not responded to offers of aid from South Korea and vaccine-sharing programmes, but prefers U.S.-made Moderna and Pfizer over China's Sinovac or British-Swedish Astrazeneca shots, according to South Korean officials.

Both the U.S. vaccines rely on technology known as mRNA, and require super-cold storage. Sinovac or AstraZeneca vaccines can be transported and stored at normal refrigerator temperatures.

"Moderna and Pfizer vaccines require a low-temperature storage system, which does not have," said Moon Jin-soo, director of the Institute for Health and Unification Studies at Seoul National University. "It would require a ton of additional materials to use them for inoculation." South Korean officials have said it is not clear whether the North has access to such storage systems.

In March, the U.N. Security Council gave a sanctions exemption to the UNICEF to ship such "cold-chain" equipment to North Korea to assist with vaccinations.

The items included three walk-in cold rooms for "storage of routine immunization vaccines," though it was not immediately confirmed whether they had been shipped amid strict border restrictions.

According to the North's latest Voluntary National Review report presented to the U.N. last year, only 34.6% of its population had access to electricity, and the country's roads and railways were, "in general, not in standard condition." Given those conditions, only few cities could accommodate the cold storage units, experts said.

Whether North Korea can mobilise trained medical personnel on a large scale for a nationwide inoculation campaign also remains an open question.

"You need a system and trained medical experts to distribute the doses and inject the shots. I doubt the North has that," said Jacob Lee, a professor of infectious diseases at South Korea's Hallym University School of Medicine.

North Korea has inoculated children for diseases such as tuberculosis with the help of organizations. But U.N. aid agencies and most other relief groups have pulled out of the country amid extended border shutdowns.

South Korea's foreign minister, Park Jin, said on Tuesday he would ask Washington for sanctions exemptions to send needed equipment to the North if it asks.

"The most important thing is speed," said Shin Young-jeon, a professor at Hanyang University's College of Medicine in Seoul.

"The virus is already spreading fast, and without swift vaccination and immunity building, the death toll could soar to an uncontrollable level."

(Reporting by Soo-hyang Choi. Editing by Gerry Doyle)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, May 18 2022. 13:21 IST
RECOMMENDED FOR YOU
.